Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 10,867

Document Document Title
WO/2013/061724A1
Provided are a novel radical inhibitor, a composition containing the same, and a radical generation inhibition method using the same. This radical inhibitor comprises a salen complex compound of a divalent metal.  
WO/2013/059651A1
A compound having the formula (I) wherein X is S, SO or SO2; one of R1, R2, and R3 is O and the others of R1, R2 and R3 are independently, the same or different, CH2, or CR13 wherein, R13 is an alkyl group, an alkenyl group, an alkynyl g...  
WO/2013/057675A1
The present invention relates to an alkenylglucosinolate composition which under stomach conditions generates the corresponding epithionitrile derivative, which has detoxifying properties. It also relates to a food composition containing...  
WO/2013/055385A3
The invention generally relates to methods of treating a patient having, and/or at risk of, oxidative distress disorders and/or age-related disorders. The disclosure also generally relates to methods of treating memory impairment or enha...  
WO/2013/055385A2
The invention generally relates to methods of treating a patient having, and/or at risk of, oxidative distress disorders and/or age-related disorders. The disclosure also generally relates to methods of treating memory impairment or enha...  
WO/2013/051389A1
Provided are: a medicinal agent responsive to a metal salen complex compound, which can neutralize the cytotoxity of the metal salen complex compound and has a detoxifying activity; and a system for controlling the in vivo behavior of a ...  
WO/2013/051680A1
The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or removal performance, whereby a toxic substance inside the body can be adsorbed or...  
WO/2013/047082A1
The present invention addresses the problem of providing a means for efficiently degrading an exogenous opioid peptide. Provided is an exogenous opioid peptide-degrading enzyme comprising one or more components selected from the group co...  
WO/2013/049519A2
The present invention relates to compositions, kits and methods for the administration of compositions and kits for supplementation with twelve carbon chain fatty acids or twelve carbon chain acylglycerols; and specifically for the suppl...  
WO/2013/042065A2
The invention provides compounds which are inhibitor of ricin, abrin, Shiga or saporin and which have a bipartite configuration comprising an aromatic heterocyclic structure resembling an adenine moiety in size and shape connected at the...  
WO/2013/043085A8
The invention relates to various fields of medicine, pharmaceutics and pharmacology and the chemical pharmaceutical, pharmaceutical and parapharmaceutical industry, and specifically concerns a novel class of agents which exhibit modulato...  
WO/2013/041090A1
The invention relates to the use of klinoptilolith or klinoptilolith-containing mixtures for producing medicinal products or other pharmaceutical products, for the absorption and removal of caesium ions from the human or animal organism....  
WO/2013/043085A1
The invention relates to various fields of medicine, pharmaceutics and pharmacology and the chemical pharmaceutical, pharmaceutical and parapharmaceutical industry, and specifically concerns a novel class of agents which exhibit modulato...  
WO/2013/042065A4
The invention provides compounds which are inhibitor of ricin, abrin, Shiga or saporin and which have a bipartite configuration comprising an aromatic heterocyclic structure resembling an adenine moiety in size and shape connected at the...  
WO/2013/042065A3
The invention provides compounds which are inhibitor of ricin, abrin, Shiga or saporin and which have a bipartite configuration comprising an aromatic heterocyclic structure resembling an adenine moiety in size and shape connected at the...  
WO/2013/029634A3
The invention relates to a composition from extract of Myrciaria dubia and Echinacea purpurea,which has a synergistic effect. The composition of the invention has potentiated antioxidant and anti-influenza properties, as well as a high i...  
WO/2013/032893A1
The present invention provides compositions and methods for treating or protecting mucosal tissues from damage associated with radiation and/or chemotherapy. Specifically, the instant invention is directed to inhibitors of prolyl hydroxy...  
WO/2013/029034A1
The inventive tripartite composition is a combination of fucoidan, trans-resveratrol, and bovine colostrum in effective quantities, in the range of from 1 : 1.5: 1.5 to 1 : 10: 10 in weight percent. This composition provides antioxidant ...  
WO/2013/026151A1
Stevia is a zero or low calorie natural sweetener that can be extracted from the leaves of Stevia Rebaudiana. An improved stevia rebaudiana extract is presently disclosed having low or no after-taste as well as a process for obtaining. T...  
WO/2013/023443A1
The present invention aims at providing an application of a peptide of a soft-shell turtle in preparing a medicament having a protective feature against radiation hazards. The oligopeptide of the soft-shell turtle of the present inventio...  
WO/2013/021093A1
The present invention relates to the use of cardiotrophin-1 (CT-1) for the prevention and/or treatment of acute renal injury, specially of acute kidney injury induced by nephrotoxic agents, such as contrast agents, antibiotics, immunosup...  
WO/2013/022058A1
The purpose of the present invention is to establish a novel therapy method for hyperbilirubinemia and, therefore, to provide a bilirubin excretion enhancer. The present invention provides a bilirubin excretion enhancer comprising, as an...  
WO/2013/019145A3
The invention relates to the field of veterinary medicine and animal husbandry and, more specifically, to a method for producing a biologically active product of natural origin for use in veterinary science and animal husbandry, which ex...  
WO/2013/017475A1
The present invention discloses the use of L-Histidine to reduce Gadolinium accumulation i nto target org ans, preventing its toxic effects, after administration of gadolinium based contrast agents. The invention thus, also disclose the ...  
WO/2013/013497A1
Provided are a Hovenia Acerba drink effective at curing drunkenness, and the preparation method and use thereof in preparing anti-inebriation food and health care products. The drink is prepared from Hovenia Acerba, Flos Puerariae and Rh...  
WO/2013/016427A1
The invention concerns methods for protecting a subject in need from a deleterious effect of gluten ingestion. The invention specifically concerns the treatment of celiac disease and gluten intolerance. The invention further provides pha...  
WO/2013/011732A1
[Problem] To provide a selective hydrogenation apparatus with which a hydrogen-containing biologically applicable liquid can be obtained without changing the properties of a biologically applicable liquid. [Solution] A hydrogen-generatin...  
WO/2013/008076A1
The invention concerns a new polymorphic form of R-(+)-α-lipoic acid and a process for the preparation thereof, in addition to the compositions that contain it and its use as a medicine or food supplement.  
WO/2013/008249A3
A cell regenerating antioxidant composition and the process for preparing the same made from commonly available flowers and fruits which includes banana flowers, cucumber fruits and chickpea to regenerate and repair the cells and tissues...  
WO/2013/006055A8
The present invention relates to the fields of medical microbiology and vaccines. In particular the invention relates to a process for detergent-free preparation of outer membrane vesicles (OMV) of Gram negative bacteria for use in vacci...  
WO/2013/006055A1
The present invention relates to the fields of medical microbiology and vaccines. In particular the invention relates to a process for detergent-free preparation of outer membrane vesicles (OMV) of Gram negative bacteria for use in vacci...  
WO/2013/001890A1
[Problem] To provide a soy saponin composition having high bodily absorption characteristics. [Solution] This soyasapogenol composition contains soyasapogenol B and 3-O-D-glucuronopyranosyl soyasapogenol B. The weight ratio (B/A) of the ...  
WO/2013/003445A1
The invention provides a novel tetra-pyridine compound and a composition containing this compound for protecting and preserving cells, tissues and organs against ischemia-reperfusion injury. A method and use of the tetra-pyridine compoun...  
WO/2013/002317A1
A solid oxidized glutathione salt is produced by heating oxidized glutathione to at least 30°C while bringing the oxidized glutathione into contact with an aqueous medium composed of water and/or a water-soluble medium, in the presence ...  
WO/2012/167656A1
The invention provides spriulina polysaccharide organic bio-active iodine and application thereof. The spriulina polysaccharide organic bio-active iodine is obtained by adding spriulina polysaccharides and organic bio-active iodine into ...  
WO/2012/167346A1
The present invention relates to anti-ricin antibodies and uses thereof. More specifically, the invention relates to anti-ricin antibodies and fragments thereof as well as their use in therapy or prophylaxis.  
WO/2012/167236A1
Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.  
WO/2012/163290A1
The present invention discloses a pharmaceutical polymer and a method for quenching free radicals. Said pharmaceutical polymer comprises a glycopeptides and an aminothiol moiety which covalently bonds together. The disclosed pharmaceutic...  
WO/2012/159569A1
Provided in the present invention is an application for PRDX2 and/or PRDX6 in the preparation of a pharmaceutical composition to treat or prevent damage, aging or disease resulting from an increase in reactive oxygen species (ROS).  
WO/2012/155061A1
A method of inhibiting, preventing, or reducing damage to non-cancerous cells in a human subject during chemotherapeutic treatment or radiation treatment of cancer cells in the human subject includes administering to the human subject ar...  
WO/2012/150370A1
The present invention relates to a combination of the polyphenols resveratrol, quercetin and catechin in a molar ratio of approximately 1:1:2 or, alternatively, approximately 1:1:5, which has synergic antioxidant power. This combination ...  
WO/2012/147901A1
The present invention provides a composition for mitigating anticancer drug side effects, the composition containing isoleucine, leucine and valine as active ingredients. The composition is extremely safe and moreover will not impact the...  
WO/2012/146057A1
Disclosed is a curcuminoid injection solution mainly composed of curcuminoid, a solvent used for injection and a small amount of pH adjusting agent. Also provided is a curcuminoid intravenous injection which simply mixes the aforemention...  
WO/2012/145307A1
In an embodiment, a barrier-forming composition includes a carbohydrate gum, a humectant, and an antimicrobial agent. The composition furthermore meets the following requirements: about 0.01% ≤ C ≤ about 0.4%; about 4.5% ≤ H ≤ ab...  
WO/2012/138713A2
The present disclosure provides methods for identifying therapeutic agents that are multifunctional radical quenchers. It also provides compounds of formula (I), (II), or (II-A): and pharmaceutically acceptable salts thereof, composition...  
WO/2012/138806A3
There are provided fractions of olive mill waste. Method of preparing the fractions and uses thereof are also described.  
WO/2012/138713A3
The present disclosure provides methods for identifying therapeutic agents that are multifunctional radical quenchers. It also provides compounds of formula (I), (II), or (II-A): and pharmaceutically acceptable salts thereof, composition...  
WO/2012/129942A1
Disclosed are a chiral 3-hydroxypyrid-4-one derivative and a salt thereof. The compound is acquired by reacting methyl maltol or ethyl maltol with benzyl chloride to acquire a 3-benzyl protected maltol, then by reacting compound VII with...  
WO/2012/130834A1
The present invention relates to antibody molecules against anticoagulants, in particular dabigatran,and their use as antidotes of such anticoagulants.  
WO/2012/126047A1
The invention provides a method of treating pain, reducing inflammation and reducing skin irritation particularly itching, the method comprising administering a polypeptide comprising thymosin, or an active fragment or variant thereof or...  

Matches 301 - 350 out of 10,867